• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

位于19号染色体短臂1区3带的LTG19/ENL的两个不同部分与t(11;19)白血病有关。

Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.

作者信息

Yamamoto K, Seto M, Komatsu H, Iida S, Akao Y, Kojima S, Kodera Y, Nakazawa S, Ariyoshi Y, Takahashi T

机构信息

Laboratories of Chemotherapy, Aichi Cancer Center Research Institute, Nagoya, Japan.

出版信息

Oncogene. 1993 Oct;8(10):2617-25.

PMID:8378076
Abstract

We previously isolated cDNA clones, MLL-a and MLL-b, derived from the 11q23 breakpoint region and detected gene rearrangements with MLL-b cDNA in infantile leukemia cell lines with 11q23 abnormalities. We also showed chimeric mRNAs between MLL and genes on partner chromosomes such as 4q21 and 19p13. In the present study, we isolated overlapping MLL cDNA clones of 11 kb and demonstrated that MLL-a and MLL-b were derived from the same gene, MLL/ALL-1/HRX. Northern analysis with an MLL cDNA probe detected different signals in t(11;19) cell lines, one being sized 10 kb in two cell lines, KOCL-33 and KOCL-44, and the other being 9.2 kb in the cell line, KOPN-1. To elucidate the molecular basis for the heterogeneity, we isolated cDNA clones of a translocation-associated gene on chromosome 19, LTG19, as well as chimeric cDNAs from KOPN-1. Northern analysis with LTG19 cDNA demonstrated the identical gene, encoding serine/proline rich 559 amino acid polypeptide, to be involved in all three cell lines. Sequence comparison revealed that the LTG19 portion of the predicted chimeric protein of KOPN-1 was fused in frame and contained the C-terminal 189 amino acids. This was shorter by 366 amino acids than those of KOCL-33 and KOCL-44, also fused in frame. Reverse transcriptase-PCR analysis demonstrated complex chimeric mRNAs in cell lines and leukemia samples. Although a chimeric mRNA of KOPN-1 type was rare, its presence suggested that the shared C-terminal portion of 189 amino acids of LTG19 contains important signal(s) for malignant transformation.

摘要

我们之前从11q23断点区域分离出了cDNA克隆MLL-a和MLL-b,并在具有11q23异常的婴儿白血病细胞系中检测到了与MLL-b cDNA的基因重排。我们还展示了MLL与伙伴染色体(如4q21和19p13)上的基因之间的嵌合mRNA。在本研究中,我们分离出了11 kb的重叠MLL cDNA克隆,并证明MLL-a和MLL-b源自同一基因MLL/ALL-1/HRX。用MLL cDNA探针进行的Northern分析在t(11;19)细胞系中检测到了不同的信号,其中一个在KOCL-33和KOCL-44这两个细胞系中的大小为10 kb,另一个在KOPN-1细胞系中的大小为9.2 kb。为了阐明这种异质性的分子基础,我们分离出了19号染色体上一个易位相关基因LTG19的cDNA克隆,以及来自KOPN-1的嵌合cDNA。用LTG19 cDNA进行的Northern分析表明,同一个编码富含丝氨酸/脯氨酸的559个氨基酸多肽的基因参与了所有三个细胞系。序列比较显示,KOPN-1预测嵌合蛋白的LTG19部分是框内融合的,包含C端的189个氨基酸。这比同样框内融合的KOCL-33和KOCL-44的氨基酸短366个。逆转录酶-PCR分析在细胞系和白血病样本中显示出复杂的嵌合mRNA。尽管KOPN-1型的嵌合mRNA很少见,但其存在表明LTG19共有的189个氨基酸的C端部分含有恶性转化的重要信号。

相似文献

1
Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.位于19号染色体短臂1区3带的LTG19/ENL的两个不同部分与t(11;19)白血病有关。
Oncogene. 1993 Oct;8(10):2617-25.
2
Gene rearrangement and truncated mRNA in cell lines with 11q23 translocation.具有11q23易位的细胞系中的基因重排和截短的mRNA
Oncogene. 1993 Feb;8(2):479-85.
3
MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13.9p22上参与t(9;11)白血病的MLLT3基因编码一种富含丝氨酸/脯氨酸的蛋白质,与19p13上的MLLT1同源。
Oncogene. 1993 Nov;8(11):3085-92.
4
The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations.与t(11;14)易位相关的RCK基因不同于与t(4;11)和t(11;19)易位相关的MLL/ALL-1基因。
Cancer Res. 1992 Nov 1;52(21):6083-7.
5
A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15.一个t(11;15)将MLL与两个不同的基因融合,即15号染色体上的AF15q14和一个新基因MPFYVE。
Oncogene. 2003 Mar 6;22(9):1400-10. doi: 10.1038/sj.onc.1206273.
6
Chromosome translocations: good genes gone wrong.染色体易位:正常基因出了差错。
Pathol Biol (Paris). 1995 Mar;43(3):197-201.
7
Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation.鉴定参与11q23易位的MLL及嵌合MLL基因产物,以及MLL截短导致白血病发生的可能机制。
Oncogene. 1996 Nov 7;13(9):1945-53.
8
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.人类肺泡软组织肉瘤的der(17)t(X;17)(p11;q25)将TFE3转录因子基因与位于17q25的一个新基因ASPL融合。
Oncogene. 2001 Jan 4;20(1):48-57. doi: 10.1038/sj.onc.1204074.
9
LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family.LPP是脂肪瘤中HMGIC的首选融合伙伴基因,是LIM蛋白基因家族的一个新成员。
Genomics. 1996 Aug 15;36(1):118-29. doi: 10.1006/geno.1996.0432.
10
A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.慢性粒单核细胞白血病转化为急性髓系白血病时出现的一种携带t(11;19)(q23;p13.1)的新型MLL-ELL融合转录变体形式。
Cancer Genet Cytogenet. 2008 Jul 15;184(2):109-12. doi: 10.1016/j.cancergencyto.2008.04.001.

引用本文的文献

1
Rare and Novel Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia.儿科 T 细胞急性淋巴细胞白血病中的罕见和新型融合基因。
Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):121-131. doi: 10.21873/cgp.20247.
2
Misguided transcriptional elongation causes mixed lineage leukemia.转录延伸错误导致混合谱系白血病。
PLoS Biol. 2009 Nov;7(11):e1000249. doi: 10.1371/journal.pbio.1000249. Epub 2009 Nov 24.
3
The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.
混合谱系白血病蛋白(MLL)的氨基末端可促进细胞周期停滞和单核细胞分化。
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2797-802. doi: 10.1073/pnas.040574897.
4
AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).AF5q31是一个新发现的与AF4相关的基因,在伴有ins(5;11)(q31;q13q23)的婴儿急性淋巴细胞白血病中与MLL融合。
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14535-40. doi: 10.1073/pnas.96.25.14535.
5
The role of the immune system in anti-tumour responses. Potential for drug therapy.免疫系统在抗肿瘤反应中的作用。药物治疗的潜力。
Drugs Aging. 1995 Oct;7(4):266-77. doi: 10.2165/00002512-199507040-00002.